Does Globus Medical (GMED) Have the Potential to Rally 38.85% as Wall Street Analysts Expect?

Globus Medical (GMED) carries a consensus price target implying 38.9% upside. The article is cautiously constructive, noting that while price targets are often unreliable, an upward trend in earnings estimate revisions could support near-term share gains. The piece is primarily analyst commentary rather than a new company-specific event.

Analysis

Globus Medical (GMED) carries a consensus price target implying 38.9% upside. The article is cautiously constructive, noting that while price targets are often unreliable, an upward trend in earnings estimate revisions could support near-term share gains. The piece is primarily analyst commentary rather than a new company-specific event.